178 related articles for article (PubMed ID: 26503966)
1. Total Short-term Variability in Biomarkers of Hyperglycemia in Older Adults.
Parrinello CM; Lutsey PL; Couper D; Eckfeldt JH; Steffes MW; Coresh J; Selvin E
Clin Chem; 2015 Dec; 61(12):1540-1. PubMed ID: 26503966
[No Abstract] [Full Text] [Related]
2. The quest for the perfect biomarker of long-term glycemia: new studies, new trials and tribulations.
Foo JP; Mantzoros CS
Metabolism; 2011 Dec; 60(12):1651-4. PubMed ID: 21820137
[No Abstract] [Full Text] [Related]
3. Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.
Parrinello CM; Selvin E
Curr Diab Rep; 2014; 14(11):548. PubMed ID: 25249070
[TBL] [Abstract][Full Text] [Related]
4. Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.
Parrinello CM; Sharrett AR; Maruthur NM; Bergenstal RM; Grams ME; Coresh J; Selvin E
Diabetes Care; 2016 Apr; 39(4):589-95. PubMed ID: 26681712
[TBL] [Abstract][Full Text] [Related]
5. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
[TBL] [Abstract][Full Text] [Related]
6. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.
Jung M; Warren B; Grams M; Kwong YD; Shafi T; Coresh J; Rebholz CM; Selvin E
J Diabetes; 2018 Apr; 10(4):276-285. PubMed ID: 29055090
[TBL] [Abstract][Full Text] [Related]
7. Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.
Juraschek SP; Steffes MW; Selvin E
Clin Chem; 2012 Dec; 58(12):1648-55. PubMed ID: 23019309
[TBL] [Abstract][Full Text] [Related]
8. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
9. Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.
Selvin E; Warren B; He X; Sacks DB; Saenger AK
Clin Chem; 2018 May; 64(5):843-850. PubMed ID: 29436378
[TBL] [Abstract][Full Text] [Related]
10. Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
Ding N; Kwak L; Ballew SH; Jaar B; Hoogeveen RC; Ballantyne CM; Sharrett AR; Folsom AR; Heiss G; Salameh M; Coresh J; Hirsch AT; Selvin E; Matsushita K
Atherosclerosis; 2018 Jul; 274():86-93. PubMed ID: 29753232
[TBL] [Abstract][Full Text] [Related]
11. Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c.
Tommerdahl KL; Brinton JT; Vigers T; Nadeau KJ; Zeitler PS; Chan CL
Pediatr Diabetes; 2019 Dec; 20(8):1080-1086. PubMed ID: 31469470
[TBL] [Abstract][Full Text] [Related]
12. The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study.
George C; Matsha TE; Korf M; Zemlin AE; Erasmus RT; Kengne AP
BMC Nephrol; 2020 Jan; 21(1):32. PubMed ID: 32000712
[TBL] [Abstract][Full Text] [Related]
13. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
[TBL] [Abstract][Full Text] [Related]
14. Alternative markers of hyperglycemia and risk of diabetes.
Juraschek SP; Steffes MW; Miller ER; Selvin E
Diabetes Care; 2012 Nov; 35(11):2265-70. PubMed ID: 22875225
[TBL] [Abstract][Full Text] [Related]
15. [Laboratory markers for glycemia and their target].
Noda M; Izumi K
Nihon Rinsho; 2002 Sep; 60 Suppl 9():667-74. PubMed ID: 12387067
[No Abstract] [Full Text] [Related]
16. Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.
Selvin E; Rawlings AM; Lutsey PL; Maruthur N; Pankow JS; Steffes M; Coresh J
Circulation; 2015 Jul; 132(4):269-77. PubMed ID: 26022911
[TBL] [Abstract][Full Text] [Related]
17. Beyond self-monitored plasma glucose and HbA1c: the role of non-traditional glycaemic markers in gestational diabetes mellitus.
Mendes N; Tavares Ribeiro R; Serrano F
J Obstet Gynaecol; 2018 Aug; 38(6):762-769. PubMed ID: 29620435
[TBL] [Abstract][Full Text] [Related]
18. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
[TBL] [Abstract][Full Text] [Related]
19. HbA1c, Fructosamine, and Glycated Albumin in the Detection of Dysglycaemic Conditions.
Ribeiro RT; Macedo MP; Raposo JF
Curr Diabetes Rev; 2016; 12(1):14-9. PubMed ID: 26126638
[TBL] [Abstract][Full Text] [Related]
20. An additional measurement of glycated albumin can help prevent missed diagnosis of diabetes in Chinese population.
He X; Ying L; Ma X; Shen Y; Su H; Peng J; Wang Y; Bao Y; Zhou J; Jia W
Clin Chim Acta; 2017 Dec; 475():188-192. PubMed ID: 29061312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
